Viking Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Viking Therapeutics 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About VKTX

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. 

CEO
Brian Lian
CEOBrian Lian
Employees
36
Employees36
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2012
Founded2012
Employees
36
Employees36

VKTX Key Statistics

Market cap
3.36B
Market cap3.36B
Price-Earnings ratio
-26.29
Price-Earnings ratio-26.29
Dividend yield
—
Dividend yield—
Average volume
4.45M
Average volume4.45M
High today
$30.14
High today$30.14
Low today
$26.52
Low today$26.52
Open price
$27.75
Open price$27.75
Volume
3.16M
Volume3.16M
52 Week high
$89.10
52 Week high$89.10
52 Week low
$24.41
52 Week low$24.41

VKTX News

Seeking Alpha 1d
Viking Therapeutics inks production deal for obesity drug

Viking Therapeutics (NASDAQ:VKTX) traded higher in the premarket on Tuesday after the company announced a multi-year production agreement with the contract manu...

Viking Therapeutics inks production deal for obesity drug

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.